We are live on ! Find out more
HP

Hikari Power Portfolio holdings

AUM $855M Turnover 22.64%
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
+1.22%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$908M
AUM Growth
+$58.8M
Cap. Flow
+$51.7M
Cap. Flow %
5.69%
Top 10 Hldgs %
54.34%
Holding
148
New
51
Increased
22
Reduced
18
Closed
20
Avg Time Held
1.3 years
Top 10 Avg Time Held
2 years
Top 20 Avg Time Held
2.4 years

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$13.1M
2
KHC icon
The Kraft Heinz Company
KHC
+$9.21M
3
CL icon
Colgate-Palmolive
CL
+$7.57M
4
GIS icon
General Mills
GIS
+$7.48M
5
JNJ icon
Johnson & Johnson
JNJ
+$6.35M

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$11.5M
2
NOV icon
NOV
NOV
+$4.4M
3
DVA icon
DaVita
DVA
+$4.27M
4
NVO icon
Novo Nordisk
NVO
+$4.03M
5
DO icon
Diamond Offshore Drilling
DO
+$2.82M

Sector Composition

Rank Sector Weight
1 Financials 35.29%
2 Healthcare 22.02%
3 Industrials 11.31%
4 Technology 8.19%
5 Materials 5.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
MA icon
51
Mastercard
MA
$540B
$1.97M 0.22%
10,000
– –
2014 Q1
17 quarters
MO icon
52
Altria Group
MO
$123B
$1.85M 0.2%
32,500
+11,300
+53% +$652K
2018 Q1
1 quarter
JKHY icon
53
Jack Henry & Associates
JKHY
$11B
$1.79M 0.2%
13,700
– –
2017 Q2
4 quarters
AXP icon
54
American Express
AXP
$212B
$1.73M 0.19%
17,600
– –
2014 Q1
17 quarters
AKTX icon
55
Akari Therapeutics
AKTX
$20.2M
$1.65M 0.18%
1,055
+260
+33% +$408K
2017 Q2
4 quarters
ASHR icon
56
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.34B
$1.61M 0.18%
60,700
+8,800
+17% +$261K
2017 Q2
4 quarters
PGNX
57
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$1.61M 0.18%
200,000
– –
2017 Q3
3 quarters
MCD icon
58
McDonald's
MCD
$172B
$1.58M 0.17%
10,060
– –
2014 Q4
14 quarters
MDR
59
DELISTED
McDermott International
MDR
$1.51M 0.17%
+76,638
New +$1.56M
2018 Q2
0 quarters
CHL
60
DELISTED
China Mobile Limited
CHL
$1.32M 0.15%
29,800
– –
2018 Q1
1 quarter
SRPT icon
61
Sarepta Therapeutics
SRPT
$1.88B
$1.32M 0.15%
10,000
-15,000
-60% -$1.41M
2017 Q3
3 quarters
STOR
62
DELISTED
STORE Capital Corporation
STOR
$1.01M 0.11%
36,700
– –
2017 Q3
3 quarters
SYNT
63
DELISTED
Syntel Inc
SYNT
$1M 0.11%
31,270
– –
2017 Q1
5 quarters
BTI icon
64
British American Tobacco
BTI
$125B
$976K 0.11%
+19,350
New +$1.02M
2018 Q2
0 quarters
ACAD icon
65
Acadia Pharmaceuticals
ACAD
$3.4B
$916K 0.1%
60,000
+20,000
+50% +$357K
2016 Q4
6 quarters
ALDX icon
66
Aldeyra Therapeutics
ALDX
$44.5M
$857K 0.09%
107,858
– –
2017 Q1
5 quarters
ST icon
67
Sensata Technologies
ST
$6.01B
$856K 0.09%
18,000
– –
2018 Q1
1 quarter
ADMS
68
DELISTED
Adamas Pharmaceuticals
ADMS
$775K 0.09%
30,000
– –
2017 Q3
3 quarters
DNOW icon
69
DNOW Inc
DNOW
$2.72B
$742K 0.08%
55,675
– –
2014 Q2
16 quarters
DO icon
70
DELISTED
Diamond Offshore Drilling
DO
$734K 0.08%
35,200
-151,700
-81% -$2.82M
2014 Q4
14 quarters
VWO icon
71
Vanguard FTSE Emerging Markets ETF
VWO
$124B
$717K 0.08%
17,000
+6,000
+55% +$271K
2017 Q2
4 quarters
BDSI
72
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$713K 0.08%
241,567
-258,433
-52% -$613K
2017 Q1
5 quarters
OCUL icon
73
Ocular Therapeutix
OCUL
$1.62B
$540K 0.06%
80,011
– –
2017 Q4
2 quarters
ABEO icon
74
Abeona Therapeutics
ABEO
$266M
$530K 0.06%
+1,324
New +$579K
2018 Q2
0 quarters
AKAO
75
DELISTED
Achaogen Inc
AKAO
$520K 0.06%
60,000
– –
2017 Q3
3 quarters
1 2
3
4 5

Similar funds

TPW
Talon Private Wealth The Villages, Florida $855M AUM
EWA
Evolution Wealth Advisors Aventura, Florida $855M AUM 27.24% 1-Year Est. Return
DCM
Dimension Capital Management Coral Gables, Florida $854M AUM 21.01% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $853M AUM 15.61% 1-Year Est. Return
QIM
Quest Investment Management Lake Oswego, Oregon $856M AUM 29.41% 1-Year Est. Return
AIMC
Alley Investment Management Company Lake Forest, Illinois $856M AUM 15.11% 1-Year Est. Return
F
FIFTHDELTA London, United Kingdom $853M AUM 18.22% 1-Year Est. Return
AAM
ACK Asset Management Greenwich, Connecticut $856M AUM 70.44% 1-Year Est. Return

Hikari Power's Q2 2018 Portfolio in Review

As of Q2 2018, Hikari Power held 148 positions worth $908M, up 6.9% from $850M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Hikari Power deployed $51.7M of net new capital in Q2 2018, opening 51 new positions and adding to 22 existing holdings. Its largest new stake was Procter & Gamble: 174,200 shares worth $13.6M.

By sector, the portfolio is most concentrated in Financials at 35% of assets, down from 38% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was IBM, an estimated $11.5M trimmed.

  • Hikari Power's largest Q2 2018 buy was Procter & Gamble: 174,200 shares worth $13.6M.
  • Hikari Power added most to The Kraft Heinz Company in Q2 2018, an estimated $9.21M increase.
  • Hikari Power's biggest Q2 2018 reduction was IBM, cutting an estimated $11.5M.
  • Hikari Power fully exited Chicago Bridge & Iron Nv in Q2 2018, selling an estimated $1.34M.
  • Hikari Power's ten largest holdings make up 54% of its $908M portfolio in Q2 2018.
  • Hikari Power opened 51 new positions and closed 20 in Q2 2018.
  • Hikari Power's portfolio value rose 6.9% quarter-over-quarter to $908M.

Based on Hikari Power's 13F filing for Q2 2018, filed 2 Aug 2018.